Christi Shaw

Christi Shaw has served on our Board since November 2018 and is a member of the Compensation & Human Resources Committee and the Nominating & Governance Committee. Ms. Shaw currently serves as Chief Executive Officer of Kite, the cell therapy company of Gilead. Prior to this role, Ms. Shaw was Senior Vice President of Eli Lilly Company, and President of Lilly Bio-Medicines, the business within Eli Lilly Company that comprises neuroscience and immunology. In former roles, Ms. Shaw held several leadership roles, including U.S. Country Head and President of Novartis Pharmaceutical Corporation and North American Region Head of Novartis Oncology. Previously, Ms. Shaw has also held several leadership positions at Johnson & Johnson, Inc. Ms. Shaw serves as an executive board member of the Biotechnology Innovation Organization and is the co-founder of the More Moments More Memories Foundation to assist people with cancer and their caregivers. Ms. Shaw holds an MBA from the University of Wisconsin and a BBA in marketing from Iowa State University. Ms. Shaw’s extensive senior leadership experience within the healthcare industry and service as a Board Member of a large trade organization, along with her independence, make her a valuable member of our Board.